Class information for:
Level 1: STATINS//RHABDOMYOLYSIS//STATIN INTOLERANCE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
7494 1362 38.4 82%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
171 3       MONASCUS//CITRININ//MONASCUS PURPUREUS 58457
419 2             STATINS//EZETIMIBE//SIMVASTATIN 16502
7494 1                   STATINS//RHABDOMYOLYSIS//STATIN INTOLERANCE 1362

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 STATINS authKW 513970 30% 6% 410
2 RHABDOMYOLYSIS authKW 406277 12% 11% 163
3 STATIN INTOLERANCE authKW 352409 2% 60% 26
4 MYOPATHY authKW 344908 12% 9% 165
5 CERIVASTATIN authKW 304391 3% 35% 39
6 HMG COA REDUCTASE INHIBITORS authKW 212108 7% 10% 99
7 MYALGIA authKW 196905 4% 17% 51
8 STATIN MYOPATHY authKW 135618 1% 55% 11
9 SIMVASTATIN authKW 131885 8% 5% 111
10 MUSCLE SYMPTOMS authKW 109843 1% 70% 7

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 4500 35% 0% 470
2 Medicine, General & Internal 1622 17% 0% 233
3 Cardiac & Cardiovascular System 1564 14% 0% 195
4 Toxicology 426 6% 0% 82
5 Peripheral Vascular Diseases 318 5% 0% 71
6 Rheumatology 199 2% 0% 34
7 Primary Health Care 119 1% 0% 14
8 Clinical Neurology 97 5% 0% 72
9 Endocrinology & Metabolism 48 4% 0% 49
10 Public, Environmental & Occupational Health 45 4% 0% 52

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SCRIPPS MERCY CLIN 89671 0% 100% 4
2 HENRY LOW HEART 66763 2% 14% 21
3 DRUG SURVEILLANCE EXTREMADURA 44836 0% 100% 2
4 SLOVENIA INTERNAL MED 44836 0% 100% 2
5 OFF HLTH PROMOT DIS PREVENT 34148 1% 19% 8
6 AMBULAT HLTH CLIN 22418 0% 100% 1
7 ANTICOAGULAT CARDIAC RISK SERV 22418 0% 100% 1
8 AREA HLTH EDUC NE 22418 0% 100% 1
9 ARZNEIMITTELINFORMAT ARZNEIMITTELBERATUNGSDIENS 22418 0% 100% 1
10 BIOSTAT BIOINFORMAT FAMILY PREVENT MED 22418 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF CLINICAL LIPIDOLOGY 19819 2% 4% 24
2 ANNALS OF PHARMACOTHERAPY 5059 3% 1% 35
3 DRUG SAFETY 4265 1% 1% 20
4 PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 3114 1% 1% 18
5 EXPERT OPINION ON DRUG SAFETY 3095 1% 1% 12
6 CURRENT ATHEROSCLEROSIS REPORTS 2729 1% 1% 9
7 AMERICAN JOURNAL OF CARDIOLOGY 2568 4% 0% 56
8 CLINICAL PHARMACOLOGY & THERAPEUTICS 2561 2% 0% 26
9 CURRENT OPINION IN LIPIDOLOGY 2414 1% 1% 12
10 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 1788 2% 0% 24

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 STATINS 513970 30% 6% 410 Search STATINS Search STATINS
2 RHABDOMYOLYSIS 406277 12% 11% 163 Search RHABDOMYOLYSIS Search RHABDOMYOLYSIS
3 STATIN INTOLERANCE 352409 2% 60% 26 Search STATIN+INTOLERANCE Search STATIN+INTOLERANCE
4 MYOPATHY 344908 12% 9% 165 Search MYOPATHY Search MYOPATHY
5 CERIVASTATIN 304391 3% 35% 39 Search CERIVASTATIN Search CERIVASTATIN
6 HMG COA REDUCTASE INHIBITORS 212108 7% 10% 99 Search HMG+COA+REDUCTASE+INHIBITORS Search HMG+COA+REDUCTASE+INHIBITORS
7 MYALGIA 196905 4% 17% 51 Search MYALGIA Search MYALGIA
8 STATIN MYOPATHY 135618 1% 55% 11 Search STATIN+MYOPATHY Search STATIN+MYOPATHY
9 SIMVASTATIN 131885 8% 5% 111 Search SIMVASTATIN Search SIMVASTATIN
10 MUSCLE SYMPTOMS 109843 1% 70% 7 Search MUSCLE+SYMPTOMS Search MUSCLE+SYMPTOMS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 TAHA, DA , DE MOOR, CH , BARRETT, DA , GERSHKOVICH, P , (2014) TRANSLATIONAL INSIGHT INTO STATIN-INDUCED MUSCLE TOXICITY: FROM CELL CULTURE TO CLINICAL STUDIES.TRANSLATIONAL RESEARCH. VOL. 164. ISSUE 2. P. 85 -109 102 68% 15
2 GOLOMB, BA , EVANS, MA , (2008) STATIN ADVERSE EFFECTS A REVIEW OF THE LITERATURE AND EVIDENCE FOR A MITOCHONDRIAL MECHANISM.AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. VOL. 8. ISSUE 6. P. 373 -418 182 31% 188
3 AUER, J , SINZINGER, H , FRANKLIN, B , BERENT, R , (2016) MUSCLE- AND SKELETAL-RELATED SIDE-EFFECTS OF STATINS: TIP OF THE ICEBERG?.EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. VOL. 23. ISSUE 1. P. 88 -110 78 55% 6
4 STROES, ES , THOMPSON, PD , CORSINI, A , VLADUTIU, GD , RAAL, FJ , RAY, KK , RODEN, M , STEIN, E , TOKGOZOGLU, L , NORDESTGAARD, BG , ET AL (2015) STATIN-ASSOCIATED MUSCLE SYMPTOMS: IMPACT ON STATIN THERAPY-EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL STATEMENT ON ASSESSMENT, AETIOLOGY AND MANAGEMENT.EUROPEAN HEART JOURNAL. VOL. 36. ISSUE 17. P. 1012 -1022B 49 50% 105
5 NEEDHAM, M , MASTAGLIA, FL , (2014) STATIN MYOTOXICITY: A REVIEW OF GENETIC SUSCEPTIBILITY FACTORS.NEUROMUSCULAR DISORDERS. VOL. 24. ISSUE 1. P. 4 -15 70 55% 39
6 MUNTEAN, DM , THOMPSON, PD , CATAPANO, AL , STASIOLEK, M , FABIS, J , MUNTNER, P , SERBAN, MC , BANACH, M , (2017) STATIN-ASSOCIATED MYOPATHY AND THE QUEST FOR BIOMARKERS: CAN WE EFFECTIVELY PREDICT STATIN-ASSOCIATED MUSCLE SYMPTOMS?.DRUG DISCOVERY TODAY. VOL. 22. ISSUE 1. P. 85 -96 72 64% 0
7 MURLASITS, Z , RADAK, Z , (2014) THE EFFECTS OF STATIN MEDICATIONS ON AEROBIC EXERCISE CAPACITY AND TRAINING ADAPTATIONS.SPORTS MEDICINE. VOL. 44. ISSUE 11. P. 1519 -1530 63 72% 6
8 BAER, AN , WORTMANN, RL , (2007) MYOTOXICITY ASSOCIATED WITH LIPID-LOWERING DRUGS.CURRENT OPINION IN RHEUMATOLOGY. VOL. 19. ISSUE 1. P. 67 -73 51 89% 44
9 APOSTOLOPOULOU, M , CORSINI, A , RODEN, M , (2015) THE ROLE OF MITOCHONDRIA IN STATIN-INDUCED MYOPATHY.EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. VOL. 45. ISSUE 7. P. 745 -754 50 71% 8
10 JOY, TR , HEGELE, RA , (2009) NARRATIVE REVIEW: STATIN-RELATED MYOPATHY.ANNALS OF INTERNAL MEDICINE. VOL. 150. ISSUE 12. P. 858-U63 49 68% 165

Classes with closest relation at Level 1


Rank Class id link
1 9257 PRAVASTATIN//HMG COA REDUCTASE INHIBITORS//MEVALONIC ACID
2 18626 PITAVASTATIN//NK 104//CAS 147526 32 7
3 35818 HYPERCKEMIA//ASYMPTOMATIC CK ELEVATION//IDIOPATHIC HYPER CK EMIA
4 5456 OATP1B1//SLCO1B1//OATP
5 413 STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN
6 14580 POSTTRANSPLANT HYPERCHOLESTEROLEMIA//TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS
7 10374 FENOFIBRATE//FENOFIBRIC ACID//FIBRATES
8 9366 PCSK9//PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9//ALIROCUMAB
9 13608 EZETIMIBE//NPC1L1//CHOLESTEROL ABSORPTION INHIBITOR
10 14156 STATINS//SIMVASTATIN//P DIS TB INTERNAL MED

Go to start page